Michael Nurmohamed
0000-0002-6274-1934
11 papers found
Refreshing results…
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases
Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study
Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)
Hypoglycaemia following JAK inhibitor treatment in patients with diabetes
Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial
Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial
A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial
Development and Evaluation of a Smartphone Application for Self-Monitoring of Rheumatoid Arthritis Disease Activity: Results of Two Pilot Studies and Design of a Randomized Controlled Trial (Preprint)
Missing publications? Search for publications with a matching author name.